Previous Article | Next Article 
Applied and Environmental Microbiology, August 2001, p. 3530-3541, Vol. 67, No. 8
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.8.3530-3541.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Identification and Functional Characterization of
CbaR, a MarR-Like Modulator of the cbaABC-Encoded
Chlorobenzoate Catabolism Pathway
Miguel A.
Providenti1,2 and
R. Campbell
Wyndham1,*
Institute of Biology, Carleton University,
Ottawa, Ontario, Canada K1S 5B6,1 and
Faculty of Biology, The University, D-78457, Konstanz,
Germany2
Received 23 October 2000/Accepted 15 May 2001
 |
ABSTRACT |
In Comamonas testosteroni BR60 (formerly
Alcaligenes sp. strain BR60), catabolism of the
pollutant 3-chlorobenzoate (3CBA) is initiated by enzymes
encoded by cbaABC, an operon found on composite
transposon Tn5271 of plasmid pBRC60. The
cbaABC gene product CbaABC converts 3CBA to
protocatechuate (PCA) and 5-Cl-PCA, which are then metabolized by the
chromosomal PCA meta (extradiol) ring fission pathway.
In this study, cbaA was found to possess a
70 type promoter. O2 uptake experiments with
whole cells and expression studies with
cbaA-lacZ constructs showed that
cbaABC was induced by 3CBA. Benzoate, which is not a
substrate of the 3CBA pathway, was a gratuitous inducer, and CbaR, a
MarR family repressor coded for by a divergently transcribed gene
upstream of cbaABC, could modulate induction mediated by
benzoate. Purified CbaR bound specifically to two regions of the
cbaA promoter (PcbaA); site I, a
high-affinity site, is between the transcriptional start point (position +1) and the start codon of cbaA, while site
II, a lower-affinity site, overlaps position +1. 3CBA at concentrations
as low as 40 µM interfered with binding to
PcbaA. PCA also interfered with binding, while
benzoate only weakly disrupted binding. Unexpectedly, benzoate with a
hydroxyl or carboxyl at position 3 improved CbaR binding. Data are also
presented that suggest that an unidentified regulator is encoded on the
chromosome that induces cbaABC in response to benzoate
and 3CBA.
 |
INTRODUCTION |
The chlorinated benzoic acids (CBA)
are a common class of pollutants that occur in the environment as a
result of intentional introduction (e.g., in the form of herbicides) or
incomplete bacterial metabolism of some accidentally released
chemicals (e.g., polychlorinated biphenyls) (46).
Bacteria possess a remarkable assortment of metabolic pathways for
biodegradation of CBA, and the innate ability of bacteria to degrade
CBA has been exploited for bioremediation of contaminated sites
(47). Several aerobic degradation pathways have been
characterized at the biochemical and genetic levels. The most
intensively studied pathway is encoded by the clc
genes of Pseudomonas putida that specify
intradiol ring fission of 3-chlorocatechol, a metabolite generated by
nonspecific activity of benzoate or toluate dioxygenases with
3-chlorobenzoate (3CBA) (19). In contrast, the
cba-encoded pathway involves a dioxygenase and a
dehydrogenase that convert 3CBA, 4CBA, or 3,4-dichlorobenzoate
to the vicinal diol intermediates protocatechuate (PCA) and 5-Cl-PCA
(Fig. 1A) (40, 41). Other
CBA degradation operons include the cbd-encoded pathway of
Burkholderia cepacia (22) and the
ohb-encoded pathway of Pseudomonas aeruginosa
(60), both of which specify dioxygenase-mediated conversion of 2CBA to catechol; the fcb pathway of
Arthrobacter globiformis for conversion of 4CBA to
4-hydroxybenzoate by a coenzyme A ligase and a hydrolase
(61); and an Alcaligenes sp. pathway that
converts 3CBA to 3-hydroxybenzoate (31, 32). Proven or putative regulatory factors for these pathways are encoded by genes
closely linked to the catabolic operons. These factors include ClcR, a
LysR-like regulator for clc (9); CbdR, an
AraC-like regulator for cbd (22); and OhbR, an
IclR-like regulator for ohb (60).

View larger version (31K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Physical and restriction map of 3CBA catabolism
transposon Tn5271 found on plasmid pBRC60 of C.
testosteroni BR60. The solid arrows indicate various genes,
including cbaABC, which encode the dioxygenase (CbaAB)
and dehydrogenase (CbaC) that convert 3CBA to PCA or 5-Cl-PCA;
cbaR, which codes for a regulatory protein (this study);
the transposase tnpA gene of the two copies of
IS1071; and an ORF that codes for a truncated aryl
coenzyme A ligase-like product (ORF 8). Flanking tnpA
are the left and right inverted repeats of IS1071 (open
triangles). (B) Restriction map of EcoRI fragment 11 (E11) from pBRC60 and schematic diagrams of lacZ
constructs made to study expression of cbaA and
cbaR. Note that lacZ (grey boxes) is not
drawn to scale.
|
|
The cbaABC operon is located in composite transposon
Tn5271 (Fig. 1A) found on the self-transmissible IncP
plasmid pBRC60 (38, 67). Despite the potential for being
mobilized to members of various subclasses of the class
Proteobacteria (14, 20, 21, 47, 65), the
natural host range of this plasmid includes primarily members of
the
subclass of the Proteobacteria, particularly strains
that degrade PCA, the product of CbaABC-mediated catabolism of CBA, by
an extradiol pathway (39). From an ecological point of
view, little is known about factors that limit the horizontal spread of
this mobile pathway. We therefore sought to better understand regulation of cbaABC expression, not only because horizontal
transfer in contaminated environments brings this operon into a variety of genetic backgrounds and we are curious about whether the capacity to
effectively regulate cbaABC plays a role in determining the host range of these genes, but also because cbaABC encodes
an additional pathway by which bacteria metabolize CBA and thus has potential applications in bioremediation of contaminated sites. We
therefore characterized induction of cbaABC in the original host, and in this report we show that a cis-encoded
MarR-like regulator, CbaR, plays a role in modulating expression of
cbaABC. We also present evidence that a chromosomally
encoded protein may be involved in regulating this operon.
 |
MATERIALS AND METHODS |
Bacterial strains, plasmids, and growth conditions.
Strains
and plasmids used in this study are listed in Table
1. Escherichia coli was
routinely grown at 37°C in Luria-Bertani medium (1% [wt/vol]
tryptone, 0.5% [wt/vol] yeast extract, 0.5% [wt/vol] NaCl)
containing ampicillin (250 mg liter
1),
kanamycin (40 mg liter
1), or chloramphenicol
(50 mg liter
1), as required. Comamonas
testosteroni strains (formerly Alcaligenes sp. strains
[see below]) were grown as described below in minimal medium A
(64) containing 10 mM succinate, aromatic substrate at a
concentration of 4 mM, and chloramphenicol (50 to 100 mg liter
1), as required. All chemicals and
antibiotics were purchased from Sigma-Aldrich (Oakville, Ontario,
Canada). When necessary, growth media were solidified by adding agar to
a final concentration of 1.6% (wt/vol).
DNA sequencing and sequence analysis.
To add to the
phenotypic characteristics previously determined for 3CBA-degrading
strain BR60(pBRC60) (67), both strands of the first 523 bases of the 16S rRNA gene were sequenced by MIDI Labs (Newark, Del.)
by using primers that anneal beginning at positions 5 and 531 in the
16S rRNA gene of E. coli. The sequences of both strands of
Tn5271 DNA between IS1071L and cbaA
(Fig. 1A) were determined by the chain-terminating dideoxy method with
an ABI Prism automated sequencer (Biotechnology Research Institute, University of Ottawa, Ottawa, Ontario, Canada) using appropriate primers and pBRE11 (Table 1) as the template. This DNA was analyzed for
similarities to entries in the GenBank nonredundant database by using
the BLAST (5) network service of the National Center for
Biotechnology Information, Bethesda, Md. (http://www.ncbi.nlm.nih.gov). A divergently transcribed open reading frame (ORF) upstream of cbaA was identified and designated cbaR. Because
the putative product of this ORF showed similarity to MarR and various
other transcriptional regulators that are known to respond to aromatic compounds or control aromatic catabolism genes (see below), this region
was taken into consideration when we designed the various lacZ expression constructs described below. DNA between
cbaC and IS1071R (Fig. 1A) had been sequenced
previously and was not taken into consideration as it contains ORFs
whose products show similarity to proteins involved in uptake of
aromatic compounds (unpublished results) and a truncated aryl coenzyme
A ligase (14).
Determination of cbaA transcriptional start site
and reverse transcription (RT)-PCR assay.
The transcriptional
start of cbaA was determined by primer extension analysis as
described elsewhere (53). Briefly, C. testosteroni BR60(pBRC60) was grown to the mid-log phase in
minimal medium A containing 3CBA, which maximally induced 3CBA
degradation activity (see below). Total RNA was isolated, and primer
CBAAR (5'-CATGAGGCCGCCCATCG-3'; complementary to the
N-terminal coding region of CbaA) was annealed to it and extended with
Moloney murine leukemia virus reverse transcriptase (New England
Biolabs). During extension, [
-32P]dCTP
(Amersham Canada, Oakville, Ontario, Canada) was included in the
reaction mixture to label the product. The extension product and the
product of a sequencing reaction conducted with the same primer
(using pMP14.10 as the template) were resolved by electrophoresis on a
denaturing 8% polyacrylamide sequencing gel, and DNA was detected by
autoradiography; both of these analyses were performed by using
standard methods (55).
Levels of
cbaA RNA in induced cultures and uninduced
cultures were qualitatively compared by an RT-PCR assay, as follows.
BR60(pBRC60) was grown to the mid-log phase on minimal medium
A
containing 3CBA or succinate (a noninducing substrate as determined
by
O
2 uptake analysis [see below]), and DNA-free
total RNA was
extracted with an E.Z.N.A bacterial RNA kit (PeqLab,
Erlangen,
Germany) according to the manufacturer's instructions. CBAAR
was
annealed to equal amounts of RNA from each source and reverse
transcribed by using a RevertAid First Strand cDNA synthesis kit
(MBI Fermentas, St. Leon-Rot, Germany) as recommended by the
manufacturer.
Aliquots from the RT step were then analyzed by PCR
performed
with forward primer PCBAF
(5'-ACCAACTACATGGATCGAA-3'; the sequence
corresponds to the
extreme 5' end of the
cbaA transcript) and
primer
CBAAR as the reverse primer. The intensity of the signal
(a 167-bp
fragment) directly reflected the initial level of the
transcript. Two
independent RT-PCRs were conducted, and the PCR
products were analyzed
by agarose gel electrophoresis. As a control
to ensure that no
contaminating DNA was present in the RNA samples,
RNAs from both
sources were treated as recommended for first-strand
synthesis, except
that no reverse transcriptase was added. Aliquots
were then analyzed by
PCR as described above, and no signal was
observed.
Regulation of 3CBA degradation activity.
Control of 3CBA
catabolism in C. testosteroni BR60(pBRC60) was studied by
first determining which growth substrates other than 3CBA were capable
of inducing 3CBA degradation activity. As discussed above,
CbaABC-mediated metabolism of 3CBA generates PCA and 5-Cl-PCA, which
are then degraded by an extradiol (meta) ring fission
pathway (38). Because benzoate, 3-hydroxybenzoate, 4-hydroxybenzoate, and PCA also induce this pathway (41,
62), we tested whether 3CBA degradation activity was induced by
growth on these four aromatic substrates. Control cells were grown on succinate, a nonaromatic tricarboxylic acid cycle intermediate that
presumably does not induce activity. O2 uptake
assays were conducted as described previously (41).
Briefly, cultures were grown to the mid-log phase on one of the
substrates mentioned above, harvested, and washed, and the respiration
rates of cells with the various test compounds were determined
polarographically. For each growth substrate, two or three independent
trials were performed, and O2 consumption was
measured with replicate samples of the culture from each trial.
Spontaneous deletion of Tn5271 occurs at a high frequency
(66), and we therefore assessed the loss of the 3CBA
degradation genes for cultures grown on carbon sources other than 3CBA
by diluting and plating samples on minimal medium A agar containing
3CBA (Tn5271-proficient cells) or succinate (total count).
During the incubation period used in these experiments, there was no
noticeable loss of Tn5271.
Construction and insertion of cbaA and
cbaR expression constructs and measurement of LacZ
activity.
Additional studies were conducted to investigate the
effect of CbaR on cbaA expression. Two translational fusion
constructs were used: cbaRA'-'lacZ, which
included the gene cbaR, and
cbaA'-'lacZ1, which lacked it (Fig. 1B).
Expression of cbaR was studied by using three translational
fusion constructs which contained different amounts of DNA
upstream of the cbaR start codon (Fig. 1B). Finally, a
control expression construct (promoterless lacZ) was also
designed. Table 1 provides information on the structures and
derivations of the relevant plasmids used in these studies. The
nucleotide sequences of the junctions between cbaA' and
'lacZ in pBRCW34L and between cbaR' and
'lacZ in pBRCW27L were determined to confirm that both genes
were in frame with lacZ. The various expression constructs
were then cloned into suicide delivery vector pUTCm or pUTCmMCS.3
(Table 1) so that lacZ was transcribed in the direction opposite the direction of transcription of the chloramphenicol resistance gene, and they were mobilized from E. coli
CC118
pir and inserted into the chromosome of C. testosteroni BR6020 (Table 1) by triparental mating
(41). BR6020 is a
pBRC60/Tn5271-deficient derivative of BR60 and thus
is not able to grow on 3CBA. This strain allowed expression to be
measured in a genetic background lacking
plasmid/Tn5271-encoded functions. Transconjugants were recovered by plating cells on minimal medium A agar containing 4-hydroxybenzoate, chloramphenicol, and
5-bromo-4-chloro-3-indolyl-
-D-galactopyranoside (X-Gal). Because insertion of the expression constructs into the chromosome was random, we tested whether the location of transposition affected LacZ levels by isolating four independent transconjugants for
each construct and measuring the LacZ activity of succinate-grown cells, as described below. Levels could vary by as much as twofold; therefore, the transconjugant that had the lowest LacZ activity was
used as the sole representative in subsequent studies in which expression with that construct was measured. Transposition of the
expression constructs into the chromosome as single copies was
confirmed by Southern blotting. A Tn5271-proficient
background, which restored the ability to grow on 3CBA, was created for
the representative strains harboring an expression construct by
transferring pBRC60 from C. testosteroni BR6024(pBRC60) and
recovering transconjugants on minimal medium A agar containing 3CBA,
chloramphenicol, and X-Gal (41). The LacZ levels in cells
harboring the expression constructs were measured as described
elsewhere (55). Cultures were grown on succinate (a
noninducing substrate) and 3CBA or benzoate (inducing substrates). The
averages ± standard errors based on three independent trials are
reported below for each carbon source, and the statistical significance
of observed effects was determined by a paired t test
(P = 0.05).
Cloning and overexpression of cbaR
Affinity-purified CbaR for gel shift studies and DNase I protection
assays (described below) was obtained as follows. The gene coding for
CbaR was PCR amplified by using forward primer CBAR3958
(5'-cgggatccCTTGCAAGAGATCCTCGA-3') and reverse
primer CBAR3440
(5'-ccgagctcCTACTCCTGAGGAGATTC-3') (lowercase
letters indicates nucleotides that are not native to
cbaR, and the underlined nucleotides in the two
sequences are restriction sites for BamHI and
SacI, respectively). CBAR3958 is complementary to the
portion of cbaR coding for the N terminus but lacks the
native start codon, while CBAR3440 is complementary to the C-terminal
coding portion of cbaR up to and including the native
stop codon. The amplification product was initially cloned into
pCRScript SK(+) digested with SmaI (resulting in
pMP132.4), and the insert was sequenced to confirm that PCR
amplification had not introduced mutations. cbaR was
then placed downstream from and in frame with DNA coding for the
N-terminal affinity tag MRGSH6GS by digesting pMP132.4 with BamHI and SacI and cloning the ~550-bp
fragment that was generated into pQE30 digested with the same enzymes,
which resulted in pQE30cbaR. CbaR was then overexpressed and affinity
purified with an Ni-nitriloacetate column as recommended by the
manufacturer (Qiagen, Mississauga, Ontario, Canada), dialyzed twice for
~18 h against glycerol storage buffer (300 mM NaCl, 50 mM
NaH2PO4, 50% [vol/vol] glycerol; pH 8.0) by
using a Pierce Slyde-A-Lyzer cassette (10-kDa molecular mass cutoff;
MJS BioLynx, Brockville, Ontario, Canada), and stored at
20°C. The
protein concentration was determined by using the Bradford reagent
(Bio-Rad Laboratories, Mississauga, Ontario, Canada) with bovine serum
albumin as the standard. Based on the results of sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), the purified
extract contained traces of contaminating proteins or degradation
products (see Results). 3A). Therefore, as a control to confirm that
CbaR caused the effects observed in gel shift assays (see below), an
extract was prepared as described above from cells harboring the
expression construct with no insert.
Gel shift assays.
Binding of CbaR to DNA containing the
cbaA or cbaR transcriptional start site was
characterized by gel shift assays using three DNA templates, shown
schematically in Fig. 3B. In the initial assays we tested interactions
with two templates, templates 1 and 2. Template 1 putatively
contained the transcriptional start site of cbaR, which was
roughly mapped in expression studies (see below), and spanned
nucleotides (nt) 4098 (BglII site) to 4446 (NotI
site). Template 2 contained the transcriptional start site of
cbaA (determined by primer extension analysis [see
below]), as well as sufficient upstream DNA so that cbaA
expression was normal (as determined in expression studies with
construct cbaA'-'lacZ1 [see below]). The latter
sequence spanned nt 4446 (NotI site) to 4705 within
cbaA (ScaI site). Templates 1 and 2 were obtained by digesting pMP14.10 with NotI and BamHI and gel
purifying the ~400- and ~260-bp fragments, respectively. For more
detailed gel shift studies we used a 186-bp fragment (molecular weight,
114,000) that was similar to template 2 but slightly shorter at both
ends (Fig. 3B). The sequence of this third template, template 3, is shown in Fig. 2B, and it was generated by PCR with primers PCBA4480B (5'-CTCGGGTAAACACCTAGA-3') and CBAA4665
(5'-TCGCACCAAATCTTCGT-3'). The amplification product was
agarose gel purified and quantified by UV spectroscopy. All templates
were end labeled with digoxigenin-11-ddUTP by using terminal
transferase as recommended in the instructions for a DIG Gel Shift
kit (Roche Molecular Biochemicals, Laval, Québec, Canada).
Templates were separated from unincorporated label by spin column
chromatography (Qiagen) and treated as described below with respect to binding.
DNA binding assays were performed in a total volume of 10 µl, and the
reaction mixtures contained 2 µl of 5× binding buffer
[100 mM HEPES
(pH 7.6), 5 mM EDTA, 50 mM
(NH
4)
2SO
4,
5 mM dithiothreiotol,
1% (wt/vol) Tween 20, 150 mM KCl], 0.5 µl of
poly(dI-dC) (1 µg/µl),
0.5 µl of poly-
L-lysine (0.1 µg/µl; Roche Molecular Biochemicals),
4 ng of digoxigenin-labeled
template DNA, various amounts of amendments
depending on the experiment
(see below), and 1 to 3 µl of CbaR
in glycerol storage buffer.
Glycerol storage buffer containing
no CbaR was added as required so
that the final concentration
of glycerol was 15% (vol/vol), and
sterile distilled H
2O was added
as required to
adjust the volume of the reaction mixture to the
desired value. The
final concentration of glycerol in the binding
reaction mixtures made
loading buffer for subsequent electrophoresis
unnecessary. Samples were
kept at room temperature for 15 to 30
min and placed on ice for at
least 5 min, and then a 4- to 5-µl
aliquot of each binding reaction
mixture was applied to a nondenaturing
polyacrylamide gel (10 by 10 by
0.08 cm) at 4°C that had been
prerun for 1 to 2 h at a constant
current in a running buffer
containing Tris base, boric acid, and EDTA
(TBE) (final concentrations,
22.25, 22.25, and 0.5 mM, respectively)
(pH 8.0). The first one-third
of the gel (stacking gel) contained 3.5%
(wt/vol) polyacrylamide,
and the last two-thirds (separating gel)
contained 12% (wt/vol)
polyacrylamide; both parts of the gel contained
TBE at the same
concentration as the running buffer. Samples were
resolved by
electrophoresis at 10 V/cm for 3 to 4 h and then
transferred to
a positively charged nylon membrane (Roche Molecular
Biochemicals)
by electroblotting with TBE for 60 to 90 min at 300 mA in
a Panther
Semi-Dry electroblotter (Owl Separation Systems,
Portsmouth, N.H.).
DNA was detected by chemiluminescence with an
antidigoxigenin
system used as recommended by the manufacturer (Roche
Molecular
Biochemicals).
DNase I protection assays.
The specific areas bound by CbaR
were determined by DNase I protection assays. The two templates
([32P]PCBA and
[32P]CBAA) were identical to the 186-bp
gel shift template described above, except that one of the primers used
during amplification had been previously radioactively end labeled
using [
-32P]ATP (Amersham Canada Ltd.) and
T4 polynucleotide kinase so that only the noncoding strand
([32P]PCBA) or the coding strand
([32P]CBAA) was phosphorylated. Following
amplification, PCR products were separated from unincorporated label by
spin column chromatography (Qiagen). 32P-labeled
DNA templates (~6 ng) were bound to various amounts of CbaR with and
without 4 mM 3CBA or 4 mM 3-carboxybenzoate (see below) as
described above for the gel shift assays; the only differences were
that the binding buffer contained 5 mM MgCl2 and
2.5 mM CaCl2 and the reaction volume was 12 µl.
After binding, 2.5 × 10
3 U of DNase I
(Sigma-Aldrich) was added, and template DNA was digested at 22°C as
follows. For [32P]PCBA, 4-µl samples were
removed from the reaction mixture at 30, 60, and 120 s and
combined into one tube containing 1.5 µl of stop solution (500 mM
EDTA); for [32P]CBAA, 1.5 µl of stop solution
was added after 60 s of digestion. Three microliters of a glycerol
loading buffer was then added, and samples were placed in a boiling
water bath for 3 min. A 3-µl aliquot was applied to a denaturing
sequencing gel (8% [wt/vol] polyacrylamide, 8 M urea), and
sequencing ladders (generated with the appropriate primer using
pMP14.10 as the template) were included in adjacent lanes. Fragments
were resolved electrophoretically and visualized by autoradiography.
Nucleotide sequence accession numbers.
The nucleotide
sequences reported in this paper have been deposited in the GenBank
database under accession numbers U18133 (for CbaR) and AF345907 (for
16S ribosomal DNA).
 |
RESULTS |
Classification of strain BR60(pBRC60).
The identity of
3CBA-degrading strain BR60(pBRC60), originally described as an
Alcaligenes sp. strain (67), was not firmly established, and we therefore sequenced a 523-nt portion of the 16S
rRNA gene. This portion of the 16S rRNA gene was identical to the
corresponding portion of the 16S rRNA gene of the C. testosteroni type strain, and because BR60(pBRC60) has several
genetic and metabolic similarities to other C. testosteroni
strains (see below), Alcaligenes sp. strain BR60 is
reclassified as C. testosteroni BR60.
Identification of cbaR and determination of
cbaA transcriptional start.
BLAST analysis of DNA
upstream of Tn5271 revealed the presence of a divergently
oriented ORF beginning 667 bp upstream of cbaA (Fig. 1).
This ORF was designated cbaR and codes for a 19.4-kDa protein that exhibits identity to various members of the MarR family of
transcriptional regulators (Table 2).
Because many proteins belonging to this family respond to specific
aromatic compounds or are involved in regulating genes for metabolism
of aromatic compounds, we focused on the effect of CbaR on expression of cbaA (see below).
The transcriptional start site of
cbaA was determined in
order to better characterize the promoter of this gene. As determined
by primer extension analysis with RNA from 3CBA-grown cells, this
transcriptional start site is an adenine 99 nt upstream of the
putative
start codon (Fig.
2A). A hexamer starting
at position

12, TATAGT, is similar to the consensus
enterobacterial

10 hexamer
for
70-dependent genes (TATAAT), indicating
that
cbaA possesses a
70-like
promoter. However, no sequence similar to TTGACA, the consensus
enterobacterial

35 hexamer, was detected. An RT-PCR assay was
conducted to compare levels of
cbaA mRNA in uninduced cells
(succinate
grown) and induced cells (3CBA grown), and the intensity of
the
signal obtained with the former cells was much lower than the
intensity obtained with the latter cells (Fig.
2B), indicating
that
growth on 3CBA leads to an increase in
cbaA transcription.
This experiment also showed that CBAAR, the primer used in the
RT step
of these two assays, was specific for
cbaA mRNA.

View larger version (72K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Transcriptional initiation site of
cbaA, as determined by primer extension analysis of
total RNA isolated from 3CBA-grown C. testosteroni
BR60(pBRC60). The extension product was loaded onto a sequencing gel
next to four sequencing reaction mixtures (lanes A, C, T, and G) from
reactions conducted with the same primer. The primer extension lane was
digitally manipulated to enhance image quality. (B) RT-PCR assay to
compare levels of cbaA mRNA in succinate-grown
(uninduced) and 3CBA-grown (induced) BR60(pBRC60). The RT step was
performed with the primer used for primer extension analysis (see
Materials and Methods). For reference purposes, the PCR signal obtained
with whole cells is also shown. The lengths of DNA size standards are
indicated on the right.
|
|
Induction of 3CBA degradation activity and expression of
cbaA
In order to determine which growth substrates
induced 3CBA degradation activity, we initially investigated control of
3CBA catabolism in C. testosteroni BR60(pBRC60) by
performing O2 uptake assays with whole cells, and the
results are shown in Table 3. As
expected, maximal 3CBA degradation activity was induced by 3CBA.
Benzoate, which is not a substrate of this pathway and is not channeled
via the PCA extradiol pathway (50), gratuitously induced
3CBA degradation activity (~29% of the maximum activity). Similarly,
benzoate degradation activity was gratuitously induced by 3CBA (~22%
of the maximum activity observed following growth on benzoate).
Succinate, a nonaromatic carbon source, did not induce 3CBA activity,
nor did 3-hydroxybenzoate, 4-hydroxybenzoate, and PCA, three aromatic
carbon sources that are channeled through the PCA extradiol ring
fission pathway, suggesting that the cba pathway, at
least with respect to 3CBA, responds to the parent substrate but not to
downstream metabolites that are common to these degradative pathways
(i.e., PCA or the ring fission products). We observed good
reproducibility between trials for all cultures except those grown on
benzoate. For unknown reasons, cells exhibited variable lag phases (18 to 36 h) in the three trials before the onset of logarithmic
growth. This apparently affected O2 uptake rates with
benzoate but not with the other carbon sources (data not shown). The
results presented here are the results for the trial in which the log
phase was achieved within 18 h, the time necessary for the other
growth substrates.
View this table:
[in this window]
[in a new window]
|
TABLE 3.
Rates of oxygen consumption by C. testosteroni
BR60(pBRC60) grown on one substrate and exposed to various other
carbon sources
|
|
Control of
cbaABC-mediated catabolism of 3CBA was further
characterized by studying
cbaA expression in the presence
and absence
of CbaR. Expression levels were measured with strain BR6020
(Table
1) harboring the constructs
cbaA'-'
lacZ1
and
cbaRA'-'
lacZ (Fig.
1B) and grown on 3CBA or
the gratuitous inducer benzoate (see
above). The levels of expression
were compared to those observed
following growth on the noninducing
substrate succinate (see above).
We initially hypothesized that CbaR
was a repressor and that in
its absence we would observe constitutive
(i.e., maximal)
cbaA expression. The
Tn
5271-deficient genetic background provided by
BR6020
allowed us to specifically test its role by eliminating
trans-encoded CbaR, while reintroduction of pBRC60, which
created
a Tn
5271-proficient background, restored all
functions necessary
for growth on 3CBA and created a strain that was
essentially identical
to the parent strain, BR60(pBRC60). The results
are summarized
in Fig.
3. In
Tn
5271-deficient cells, LacZ activity under noninducing
conditions was roughly the same with both constructs. For
benzoate-grown
cells, the induction ratios compared to succinate-grown
cells
were 3.2- and 7.4-fold in BR6020 harboring
cbaRA'-'
lacZ and BR6020
harboring
cbaA'-'
lacZ1, respectively. From these
data, it appeared
that control of
cbaA was not due to simple
repression by CbaR
and that CbaR might be a modulator of
benzoate-induced activity.
In addition, because
cbaA was
induced by benzoate in the absence
of any
pBRC60/Tn
5271-encoded functions, our data suggested that
there is a benzoate-responsive chromosomally encoded regulator.

View larger version (54K):
[in this window]
[in a new window]
|
FIG. 3.
Levels of cbaA expression in C.
testosteroni BR6020 harboring different lacZ
constructs. Expression was measured with a growth substrate that did
not induce 3CBA degradation activity (succinate) or did induce this
activity (benzoate or 3CBA) in Tn5271-deficient cells
( pBRC60) and Tn5271-proficient cells (+pBRC60). The
data are averages based on three independent trials; the error bars
indicate standard errors. 3Cba, 3-chlorobenzoate.
|
|
In a Tn
5271-proficient background, the LacZ activities under
noninducing conditions were roughly the same with both constructs,
and
compared to succinate-grown cells, the induction ratios for
benzoate-grown cells (4.1- to 4.2-fold) and 3CBA-grown cells (5.5-
to
5.8-fold) were virtually the same with both constructs (Fig.
3). After
pBRC60 was introduced to create a Tn
5271-proficient
background, the levels of
cbaA expression compared to those
in
Tn
5271-deficient cells tended to decrease with both
constructs
(Fig.
3). For succinate-grown cells the effect was
insignificant
to moderate (1.1- to 1.6-fold decreases), but for
benzoate-grown
cells harboring
cbaA'-'
lacZ1 the
effect was relatively strong
(2-fold decrease), probably because of
trans-encoded CbaR from
pBRC60. For benzoate-grown cells
harboring
cbaRA'-'
lacZ, the effect
was slight
(1.2-fold), presumably because a
cis-encoded CbaR was
already provided by the construct. In BR6020 harboring the control
construct (promoterless
lacZ) and grown as described above
in
a Tn
5271-deficient or Tn
5271-proficient
background, LacZ activity
was negligible (~1 Miller
unit).
Expression of cbaR and gel shift and DNase I
footprinting assays with affinity-purified CbaR.
In order to
better understand the gene coding for CbaR, we investigated expression
of cbaR with various LacZ constructs, not only to determine
whether the levels of cbaR expression were affected by
growth conditions and genetic backgrounds that affected cbaA expression but also to roughly map the transcription starting point.
LacZ activity in BR6020 harboring cbaR'-'lacZ1
and cbaR'-'lacZ2 was very low (~20 Miller
Units), but compared to the control (see above) the activity was
significant. These levels of expression were observed in
Tn5271-deficient cells grown on succinate or benzoate and in
Tn5271-proficient cells grown on succinate or 3CBA, implying
that Tn5271-encoded functions, particularly CbaR, did not
have an effect on cbaR expression. With BR6020 harboring cbaR'-'lacZ3 in both genetic backgrounds and
grown under the same conditions, the activity was negligible (~1
Miller unit). This implied that cbaR transcription began
before nt 4098 (i.e., the BglII site defining the end
of construct cbaR'-'lacZ3) but after nt 4446 (i.e., the NotI site defining the end of construct
cbaR'-'lacZ2, in which expression was observed)
(Fig. 1B).
In an effort to determine if
cbaR coded for a functional DNA
binding protein, CbaR was tagged at the N terminus, overexpressed
in
E. coli, and affinity purified. As determined by SDS-PAGE
analysis,
affinity-purified extracts of
isopropyl-

-
D-thiogalactopyranoside
(IPTG)-induced cultures of M15(pQE30cbaR, pREP4) contained large
amounts of a protein that comigrated with the 20.1-kDa size standard
(Fig.
4A), which is very similar to the
predicted molecular mass
of CbaR with the six-histidine tag (20.7 kDa).
Initial gel shift
assays with purified CbaR were then conducted to
determine if
CbaR bound DNA containing either the transcriptional start
site
of
cbaR (template 1) or
cbaA (template 2),
and the results are
shown in Fig.
4C. CbaR did not affect migration of
template 1
but retarded migration of template 2.With template 2, two
CbaR-DNA
complexes that moved more slowly were observed; these
complexes
were designated C1 and C2, and addition of 4 mM 3CBA strongly
disrupted their formation. If unlabeled template 2 was added as
competitor DNA to a binding reaction mixture containing template
2, a
shift towards less retarded DNA was observed (data not shown).
As a
control, the effect of an affinity-purified extract from
E. coli containing the expression vector with no insert on migration
of the two DNA templates was tested, and no change was observed
(data
not shown), indicating that the effects elicited by the
extract were
caused by CbaR.

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 4.
(A) Analysis of affinity-purified CbaR by SDS-PAGE. Ten
micrograms of protein was loaded onto the gel. The positions of protein
size standards (in kilodaltons) are indicated on the left. (B)
Schematic diagram of the three DNA templates used in gel shift assays.
Template 1 putatively contains the transcriptional start site of
cbaR, while templates 2 and 3 harbor the transcriptional
start site and promoter of cbaA
(PcbaA). (C to F) Unless indicated
otherwise, each binding reaction mixture contained 0.4 µg of CbaR, 4 ng of DNA, and an aromatic compound at a concentration of 4 mM. The
positions of unbound template (Free DNA),
CbaR-PcbaA DNA complex 1 (C1), and
CbaR-PcbaA DNA complex 2 (C2) are indicated.
Template 3 was used for all assays except those whose results are shown
in panel C, which tested the effect of CbaR on the mobility of
templates 1 and 2. For template 2, the effect of including 3CBA in the
binding reaction mixture was also tested. (D) Assay to determine the
minimum concentration at which 3CBA interfered with CbaR binding to
PcbaA DNA. The concentration of 3CBA was varied,
while the amounts of CbaR and DNA were kept constant. (E) Stoichiometry
of CbaR-PcbaA DNA complex formation. The amount
of CbaR per reaction mixture was varied, while the amount of DNA was
kept constant. For reference purposes, the approximate molar ratios of
CbaR to DNA are also shown. (F) Effects of benzoate and various
hydroxylated benzoates on CbaR binding to PcbaA
DNA. 3Cba, 3-chlorobenzoate.
|
|
More detailed gel shift assays to study interactions between CbaR and
the
cbaA promoter (P
cbaA) were then
performed
by using template 3 (Fig.
4B). Experiments with a range of
3CBA
concentrations revealed that significant disruption occurred with
40 µM 3CBA (Fig.
4D). The stoichiometry of C1 and C2 formation
was
also studied, and the results are shown in Fig.
4E. Small
amounts of C1
appeared when CbaR and P
cbaA DNA were present
at
approximately equimolar concentrations, and equal amounts of
unbound DNA and C1 resulted when there was a 10-fold molar excess
of
CbaR. Small amounts of C2 were already apparent by this point,
but
equal amounts of C1 and C2 did not appear until there was
a 250-fold
molar excess of CbaR. C2 did not predominate until
there was at least a
2,500-fold molar excess of CbaR. Because
the template used in these
assays contained two CbaR binding sites
(see below), we were not able
to unambiguously determine binding
constants for
P
cbaA DNA. A final set of gel shift assays
was
conducted to determine whether other aromatic compounds disrupted
the
CbaR-P
cbaA DNA complexes. We tested the effect
of
benzoate or one of the three hydroxylated benzoates used in the
O
2 uptake experiments (see above), and the
results are presented
in Fig.
4F. Benzoate was a weak disrupter (i.e.,
it caused a small
shift of DNA towards less retarded forms);
4-hydroxybenzoate had
no effect; PCA was a strong disrupter (i.e., it
interfered with
binding at levels comparable to the 3CBA levels); and
unexpectedly,
3-hydroxybenzoate improved CbaR binding (i.e., it caused
DNA to
shift towards more retarded forms). The latter effect was also
elicited by 3-carboxybenzoate (see
below).
DNase I protection assays were then performed to determine the specific
binding sites of CbaR on P
cbaA, and the results
are presented in Fig.
5A. Approximately 6 ng of DNA was used per
reaction mixture, and according to gel shift
data presented in
Fig.
4E, the smallest amount of CbaR tested (10 ng or
a ~9-fold
molar excess compared to the amount of
P
cbaA DNA) resulted
mostly in C1 and very little
C2, while the largest amount (600
ng or an ~800-fold molar excess)
resulted in approximately equal
amounts of C1 and C2. Two protected
regions were identified: site
I (a higher-affinity site), which was
clearly evident with 10
ng of CbaR, and site II (a lower-affinity
site), which became
apparent only with larger amounts of CbaR. If 3CBA
was included
in the binding reaction mixture, neither site was
protected from
DNase I digestion. If the binding enhancer
3-carboxybenzoate was
included, protection of both sites was improved
~60-fold (i.e.,
10 ng of CbaR in the presence of 3-carboxybenzoate
protected sites
I and II as strongly as 600 ng of CbaR in the absence
of 3-carboxybenzoate).
Furthermore, it allowed us to more clearly
define nucleotides
protected within site II.

View larger version (91K):
[in this window]
[in a new window]
|
FIG. 5.
(A) DNase I protection assay to determine specific
regions of PcbaA DNA protected by CbaR. Template
DNA was end labeled with 32PO4 on the noncoding
strand (32P-PCBA) or the coding strand
(32P-CBAA). Various amounts of CbaR were added, and the
effect of 4 mM 3CBA (3Cba) or 4 mM 3-carboxybenzoate (3Crba) on
CbaR protection of two regions (sites I and II) was determined. A
sequencing reaction conducted with the appropriate primers was included
during electrophoretic resolution of DNase I-digested samples.
(B) Sequences of both strands of the template DNA used for the assay,
indicating the positions of sites I and II relative to the
transcriptional start site of cbaA (position +1); the
putative 10 hexamer; and the start codon of cbaA
(ATG). Inverted repeats found in site I and modified versions of these
repeats in site II are indicated by arrows, and bases present in both
sites are indicated by boldface type.
|
|
Site II overlaps the transcription starting point (position +1) of
cbaA, and site I is approximately 40 nt downstream (Fig.
5B). Site I possesses a 4-nt inverted repeat (IR) separated by
6 or 9 nt (5'-GTTG[N]
6/9CAAC-3'). Modified
forms of the two IRs
are present in the lower strand of site II
(5'-GTTG[N]
6TAAC-3'
or
5'-GTAG[N]
9TAAC-3').
 |
DISCUSSION |
Classification of strain BR60(pBRC60).
We reclassified
Alcaligenes sp. strain BR60(pBRC60) as C. testosteroni BR60(pBRC60) based on several metabolic and
genetic similarities between this bacterium and various other strains of the
-proteobacterium C. testosteroni (59,
62). The metabolic similarities include an inability to grow on
various carbohydrates (67); induction of the PCA
meta ring fission enzymes by growth on 3-hydroxybenzoate,
4-hydroxybenzoate, benzoate, or PCA (41); and a lower
growth rate with benzoate than with hydroxylated benzoates (62; Providenti, unpublished data). The genetic
similarities are the presence of the same partial 16S ribosomal DNA
sequence (see above) and highly homologous genes for PCA
meta ring fission pathway enzymes (J. Mampel, M. A. Providenti, R. C. Wyndham, and A. M. Cook, unpublished data).
Control of 3CBA degradation activity.
We initially
hypothesized that cbaABC was negatively regulated by CbaR,
which was consistent with the predominant role of the MarR family of
proteins (Table 2) (see below), but studies with the cbaA
expression constructs implied that the major role of CbaR may be to
modulate gratuitous induction by compounds like benzoate (see above).
Gel shift experiments showing that benzoate only weakly disrupted CbaR
binding to PcbaA supported this model (Fig. 4F).
Furthermore, previous work that showed that the cbaR region
is not required for cbaABC-mediated growth on 3CBA
(41) suggested that CbaR is not essential for
cbaA expression. Because studies with
Tn5271-deficient cells harboring construct cbaA'-'lacZ1 showed that growth on benzoate (Fig.
3) or growth on succinate in the presence of 3CBA (data not shown)
induced cbaA expression, we propose that there is a
chromosomally encoded regulator that, along with CbaR, controls
cbaABC. 3CBA and benzoate gratuitously activate each
other's pathways and exhibit similar induction spectra with respect to
3-hydroxybenzoate, 4-hydroxybenzoate, and PCA (Table 3), and we
therefore hypothesize that there is a shared regulator for the two
pathways. The cbaABC regulatory system may thus have
similarities to CatR activation of both the chromosomally encoded
catBCA operon for catechol metabolism and the
plasmid-encoded pheBA operon for phenol metabolism
(26, 44). Alternatively, we may have observed a
cross-activation phenomenon, like induction of the lower pathway of the
plasmid-encoded xyl genes in response to benzoate despite
the absence of XylS, the normal activator (10, 24, 28), or
CatR- and ClcR-mediated cross-activation of the clc- and
cat-encoded catabolic pathways (37, 45).
CbaR: expression of the gene and functional characterization.
The gene that encodes CbaR appears to be expressed at a very low level
(see above), and neither benzoate nor 3CBA, two growth substrates that
increased cbaA expression, altered the level of cbaR expression. In addition, CbaR itself does not appear to
exert control over expression of its own gene. This conclusion is
suggested by the observation that the levels of cbaR
expression were the same regardless of the presence of
Tn5271, which provided a trans-encoded CbaR (see
above), and the observation that CbaR did not bind to DNA spanning the
region putatively containing the cbaR transcription start
site (see above) (Fig. 4C). Furthermore, no sequences similar to the
two binding sites of CbaR were detected when the complete region
upstream of cbaA was analyzed.
CbaR bound the
cbaA promoter at two sites and exhibited
different affinities for these sites, protecting site I strongly and
site II less strongly (Fig.
5B). Sites I and II have many identical
bases, and IR structures were detected in site I (Fig.
5B). Although
a
direct role for the IR structures has not been determined, it
is
noteworthy that many of the sequence differences between sites
I and II
occur in the possible modified forms of the IR structures
in site II
(Fig.
5B), which may explain the different binding
affinities. By
correlating gel shift stoichiometry data (Fig.
4F) with DNase I
protection results (Fig.
5A), it was shown that
C1 represents CbaR
bound to site I while C2 represents CbaR bound
to both site I and site
II. Presumably, independent CbaR proteins
bind to each site, but this
remains to be shown. When binding
inhibitors are present, binding to
site II is affected first,
as disappearance of C2 always precedes
disappearance of C1 (Fig.
4D), presumably because the lower affinity of
CbaR for site II
makes it more susceptible to binding disrupters. This
may allow
CbaR-mediated repression at site II, which overlaps the
transcription
start site of
cbaA (Fig.
5A), to be overcome
more easily and is
probably an adaptation that increases the
sensitivity of the
cba pathway to potential substrates and
allows it to respond to the
concentrations of CBA (which are expressed
in parts per million)
typically encountered in contaminated
environments (
67). Our
gel shift assays showing that 40 µM 3CBA (~6 ppm) disrupted binding
(Fig.
4D) support this
view.
A brief survey of the effects of other aromatic compounds on CbaR
binding identified PCA as a strong disrupter of the
CbaR-P
cbaA complex (Fig.
4F), suggesting that
CbaR evolved so that it responds
to both 3CBA, the substrate of the
cba pathway, and at least one
downstream metabolite. This
may be a positive feedback mechanism
that ensures derepression of
cbaABC under conditions in which
PCA is being produced
because of CBA metabolism. Unexpectedly,
two
meta-substituted benzoates (3-hydroxybenzoate and
3-carboxybenzoate)
improved CbaR binding to
P
cbaA DNA (Fig.
4F and
5A).
To our knowledge,
this is the first time that this phenomenon
has been reported for a
MarR-like protein, and we are currently
exploring the effect in greater
detail and studying its physiological
significance. Conceivably,
improved binding by CbaR could lead
to increased repression of
cbaA, a phenomenon observed with MarR
mutant proteins that
bind more strongly to their cognate operator
and superrepress
marRAB (
3).
As a member of the MarR family of regulators, CbaR belongs to a diverse
group of proteins that control a variety of microbial
functions,
including antibiotic resistance, catabolism of various
substrates,
plant pathogenicity, and animal virulence (Table
3).
On a functional
level, CbaR exhibits some similarities to MarR,
PecS, and MexR, which
form two or three protein-DNA complexes
in a concentration-dependent
fashion when they are combined with
DNA containing the appropriate
cognate promoter; the number of
complexes reflects the number of
binding sites (
17,
35,
36,
49,
56). Furthermore, the
binding sites of MexR (
17) contain
an inverted repeat
structure (5'-GTTGA[N]
6TCAAC-3')
that is extremely
similar to one of the possible inverted repeats
detected in the
higher-affinity binding site of CbaR (see above).
Otherwise, the
binding sites for CbaR, MarR (
36), PecS
(
49), and MexR (
17)
differ with respect to
sequence, size, spacing relative to each
other, and position relative
to the transcriptional start site
and start codons for target genes.
For the most part, regulators
belonging to the MarR family are
repressors, but BadR, NhdR, and
SlyA are activators of the operons that
they control (
15,
30,
43). The organizations of genes that
encode MarR family proteins
relative to the genes that they control and
the methods by which
expression of the gene that encodes a MarR family
protein is regulated
vary substantially. Interesting contrasts include
genes that encode
MarR-like proteins that are divergently transcribed
from their
target genes, including
hpcR,
mexR,
nhhD, and
cbaR (29, 48, 52;
this study); that are
part of the same operon, including
emrR and
marR
(
4,
34); or that are part of a different operon
but are
transcribed in the same direction, including
badR
(
15).
Expression of the genes that encode some MarR-like
regulators
is subject to induction by other regulators; these genes
include
nhhD, which is induced by NhhC (
29),
and
marR, which is induced
by MarA (
4). In
addition, autorepression has been demonstrated
for
emrR,
mexR, and
marR (
4,
34,
48). For the
most part,
MarR-like proteins appear to act alone on target genes, but
in
some cases they act in concert with other regulators. An example
of
this is BadR, which works together with AadR to fully activate
the
bad genes of
Rhodopseudomonas palustris
(
15). Similarly,
PecS is part of an intricate regulatory
network which, in concert
with a variety of other regulators (both
repressors and activators),
controls or attenuates expression of a host
of physically unlinked
operons spread over the
Erwinia
chrysanthemi chromosome (
23,
54). Despite the
diversity of the MarR-like proteins, shared
features of these proteins
include an ability to respond to aromatic
compounds (Table
3) and a
conserved motif in the center of the
protein (
58) whose
function may be to bind DNA (
1).
In conclusion, we found that the
cba catabolic pathway of
C. testosteroni BR60(pBRC60) is controlled in part by CbaR,
a
cis-encoded
3CBA-responsive MarR-like regulator whose
major role may be to
modulate gratuitous induction by benzoate or
compounds like benzoate.
There also appears to be an unidentified,
chromosomally encoded
benzoate-3CBA-responsive regulator that induces
cbaABC, and we
are currently attempting to isolate this
protein in order to better
understand factors that control
cbaA expression.
 |
ACKNOWLEDGMENTS |
We thank Suzanne Paterson for invaluable assistance with primer
extension and DNase I footprinting assays, Barb Holland for construction of several clones, Christina Matula for generation of some
transconjugants, and Alasdair M. Cook and Tewes Tralau for assistance
with RT-PCR.
M.A.P. was the recipient of an Ontario Graduate Scholarship and an
Alexander von Humboldt Fellowship. This work was supported by a Natural
Sciences and Engineering Research Council of Canada grant to R.C.W.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute of
Biology, Carleton University, 1125 Colonel By Drive, Ottawa, Ontario, Canada K1S 5B6. Phone: (613) 520-2600, ext. 3651. Fax: (613) 520-2569. E-mail: cwyndham{at}ccs.carleton.ca.
 |
REFERENCES |
| 1.
|
Alekshun, M. N.,
Y. S. Kim, and S. B. Levy.
2000.
Mutational analysis of MarR, the negative regulator of marRAB expression in Escherichia coli, suggests the presence of two regions required for DNA binding.
Mol. Microbiol.
35:1394-1404[CrossRef][Medline].
|
| 2.
|
Alekshun, M. N., and S. B. Levy.
1999.
Alteration of the repressor activity of MarR, the negative regulator of the Escherichia coli marRAB locus, by multiple chemicals in vitro.
J. Bacteriol.
181:4669-4672[Abstract/Free Full Text].
|
| 3.
|
Alekshun, M. N., and S. B. Levy.
1999.
Characterization of MarR superrepressor mutants.
J. Bacteriol.
181:3303-3306[Abstract/Free Full Text].
|
| 4.
|
Alekshun, M. N., and S. B. Levy.
1997.
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon.
Antimicrob. Agents Chemother.
41:2067-2075[Medline].
|
| 5.
|
Altschul, S. F.,
T. L. Madden,
A. A. Schaffer,
J. Zhang,
Z. Zhang,
W. Miller, and D. J. Lipman.
1997.
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
Nucleic Acids Res.
25:3389-3402[Abstract/Free Full Text].
|
| 6.
|
Ariza, R. R.,
S. P. Cohen,
N. Bachhawat,
S. B. Levy, and B. Demple.
1994.
Repressor mutations in the marRAB operon that activate oxidative stress genes and multiple antibiotic resistance in Escherichia coli.
J. Bacteriol.
176:143-148[Abstract/Free Full Text].
|
| 7.
|
Brooun, A.,
J. J. Tomashek, and K. Lewis.
1999.
Purification and ligand binding of EmrR, a regulator of a multidrug transporter.
J. Bacteriol.
181:5131-5133[Abstract/Free Full Text].
|
| 8.
|
Buchmeier, N.,
S. Bossie,
C. Y. Chen,
F. C. Fang,
D. G. Guiney, and S. J. Libby.
1997.
SlyA, a transcriptional regulator of Salmonella typhimurium, is required for resistance to oxidative stress and is expressed in the intracellular environment of macrophages.
Infect. Immun.
65:3725-3730[Abstract].
|
| 9.
|
Coco, W. M.,
R. K. Rothmel,
S. Henikoff, and A. M. Chakrabarty.
1993.
Nucleotide sequence and initial functional characterization of the clcR gene encoding a LysR family activator of the clcABD chlorocatechol operon in Pseudomonas putida.
J. Bacteriol.
175:417-427[Abstract/Free Full Text].
|
| 10.
|
Cuskey, S. M., and A. B. Sprenkle.
1988.
Benzoate-dependent induction from the OP2 operator-promoter region of the TOL plasmid pWWO in the absence of known plasmid regulatory genes.
J. Bacteriol.
170:3742-3746[Abstract/Free Full Text].
|
| 11.
|
Dalrymple, B. P., and Y. Swadling.
1997.
Expression of a Butyrivibrio fibrisolvens E14 gene (cinB) encoding an enzyme with cinnamoyl ester hydrolase activity is negatively regulated by the product of an adjacent gene (cinR).
Microbiology
143:1203-1210[Abstract/Free Full Text].
|
| 12.
|
de Lorenzo, V.,
M. Herrero,
U. Jakubzik, and K. N. Timmis.
1990.
Mini-Tn5 transposon derivatives for insertion mutagenesis, promoter probing, and chromosomal insertion of cloned DNA in gram-negative eubacteria.
J. Bacteriol.
172:6568-6572[Abstract/Free Full Text].
|
| 13.
|
de Lorenzo, V., and K. N. Timmis.
1994.
Analysis and construction of stable phenotypes in gram-negative bacteria with Tn5- and Tn10-derived minitransposons.
Methods Enzymol.
235:386-405[Medline].
|
| 14.
|
Di Gioia, D.,
M. Peel,
F. Fava, and R. C. Wyndham.
1998.
Structures of homologous composite transposons carrying cbaABC genes from Europe and North America.
Appl. Environ. Microbiol.
64:1940-1946[Abstract/Free Full Text].
|
| 15.
|
Egland, P. G., and C. S. Harwood.
1999.
BadR, a new MarR family member, regulates anaerobic benzoate degradation by Rhodopseudomonas palustris in concert with AadR, an Fnr family member.
J. Bacteriol.
181:2102-2109[Abstract/Free Full Text].
|
| 16.
|
Egland, P. G.,
D. A. Pelletier,
M. Dispensa,
J. Gibson, and C. S. Harwood.
1997.
A cluster of bacterial genes for anaerobic benzene ring biodegradation.
Proc. Natl. Acad. Sci. USA
94:6484-6489[Abstract/Free Full Text].
|
| 17.
|
Evans, K.,
L. Adewoye, and K. Poole.
2001.
MexR repressor of the mexAB-oprM multidrug efflux operon of Pseudomonas aeruginosa: identification of MexR binding sites in the mexA-mexR intergenic region.
J. Bacteriol.
183:807-812[Abstract/Free Full Text].
|
| 18.
|
Figurski, D. H., and D. R. Helinski.
1979.
Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans.
Proc. Natl. Acad. Sci. USA
76:1648-1652[Abstract/Free Full Text].
|
| 19.
|
Frantz, B., and A. M. Chakrabarty.
1987.
Organization and nucleotide sequence determination of a gene cluster involved in 3-chlorocatechol degradation.
Proc. Natl. Acad. Sci. USA
84:4460-4464[Abstract/Free Full Text].
|
| 20.
|
Fulthorpe, R. R., and R. C. Wyndham.
1992.
Involvement of a chlorobenzoate-catabolic transposon, Tn5271, in community adaptation to chlorobiphenyl, chloroaniline, and 2,4-dichlorophenoxyacetic acid in a freshwater ecosystem.
Appl. Environ. Microbiol.
58:314-325[Abstract/Free Full Text].
|
| 21.
|
Fulthorpe, R. R., and R. C. Wyndham.
1991.
Transfer and expression of the catabolic plasmid pBRC60 in wild bacterial recipients in a freshwater ecosystem.
Appl. Environ. Microbiol.
57:1546-1553[Abstract/Free Full Text].
|
| 22.
|
Haak, B.,
S. Fetzner, and F. Lingens.
1995.
Cloning, nucleotide sequence, and expression of the plasmid-encoded genes for the two-component 2-halobenzoate 1,2-dioxygenase from Pseudomonas cepacia 2CBS.
J. Bacteriol.
177:667-675[Abstract/Free Full Text].
|
| 23.
|
Hugouvieux-Cotte-Pattat, N.,
G. Condemine,
W. Nasser, and S. Reverchon.
1996.
Regulation of pectinolysis in Erwinia chrysanthemi.
Annu. Rev. Microbiol.
50:213-257[CrossRef][Medline].
|
| 24.
|
Jeffrey, W. H.,
S. M. Cuskey,
P. J. Chapman,
S. Resnick, and R. H. Olsen.
1992.
Characterization of Pseudomonas putida mutants unable to catabolize benzoate: cloning and characterization of Pseudomonas genes involved in benzoate catabolism and isolation of a chromosomal DNA fragment able to substitute for xylS in activation of the TOL lower-pathway promoter.
J. Bacteriol.
174:4986-4996[Abstract/Free Full Text].
|
| 25.
|
Jenkins, J. R., and R. A. Cooper.
1988.
Molecular cloning, expression, and analysis of the genes of the homoprotocatechuate catabolic pathway of Escherichia coli C.
J. Bacteriol.
170:5317-5324[Abstract/Free Full Text].
|
| 26.
|
Kasak, L.,
R. Horak,
A. Nurk,
K. Talvik, and M. Kivisaar.
1993.
Regulation of the catechol 1,2-dioxygenase- and phenol monooxygenase-encoding pheBA operon in Pseudomonas putida PaW85.
J. Bacteriol.
175:8038-8042[Abstract/Free Full Text].
|
| 27.
|
Keen, N. T.,
S. Tamaki,
D. Kobayashi, and D. Trollinger.
1988.
Improved broad-host-range plasmids for DNA cloning in gram-negative bacteria.
Gene
70:191-197[CrossRef][Medline].
|
| 28.
|
Kessler, B.,
S. Marques,
T. Kohler,
J. L. Ramos,
K. N. Timmis, and V. de Lorenzo.
1994.
Cross talk between catabolic pathways in Pseudomonas putida: XylS-dependent and -independent activation of the TOL meta operon requires the same cis-acting sequences within the Pm promoter.
J. Bacteriol.
176:5578-5582[Abstract/Free Full Text].
|
| 29.
|
Kobayashi, M., and S. Shimizu.
1998.
Metalloenzyme nitrile hydratase: structure, regulation, and application to biotechnology.
Nat. Biotechnol.
16:733-736[CrossRef][Medline].
|
| 30.
|
Komeda, H.,
M. Kobayashi, and S. Shimizu.
1996.
Characterization of the gene cluster of high-molecular-mass nitrile hydratase (H-NHase) induced by its reaction product in Rhodococcus rhodochrous J1.
Proc. Natl. Acad. Sci. USA
93:4267-4272[Abstract/Free Full Text].
|
| 31.
|
Krooneman, J.,
E. R. B. Moore,
J. C. L. Van Velzen,
R. A. Prins,
L. J. Forney, and J. C. Gottschal.
1998.
Competition for oxygen and 3-chlorobenzoate between two aerobic bacteria using different degradation pathways.
FEMS Microbiol. Ecol.
26:171-179[CrossRef].
|
| 32.
|
Krooneman, J.,
E. B. Wieringa,
E. R. Moore,
J. Gerritse,
R. A. Prins, and J. C. Gottschal.
1996.
Isolation of Alcaligenes sp. strain L6 at low oxygen concentrations and degradation of 3-chlorobenzoate via a pathway not involving (chloro)catechols.
Appl. Environ. Microbiol.
62:2427-2434[Abstract].
|
| 33.
|
Libby, S. J.,
W. Goebel,
A. Ludwig,
N. Buchmeier,
F. Bowe,
F. C. Fang,
D. G. Guiney,
J. G. Songer, and F. Heffron.
1994.
A cytolysin encoded by Salmonella is required for survival within macrophages.
Proc. Natl. Acad. Sci. USA
91:489-493[Abstract/Free Full Text].
|
| 34.
|
Lomovskaya, O.,
K. Lewis, and A. Matin.
1995.
EmrR is a negative regulator of the Escherichia coli multidrug resistance pump EmrAB.
J. Bacteriol.
177:2328-2334[Abstract/Free Full Text].
|
| 35.
|
Martin, R. G.,
K. W. Jair,
R. E. Wolf, Jr., and J. L. Rosner.
1996.
Autoactivation of the marRAB multiple antibiotic resistance operon by the MarA transcriptional activator in Escherichia coli.
J. Bacteriol.
178:2216-2223[Abstract/Free Full Text].
|
| 36.
|
Martin, R. G., and J. L. Rosner.
1995.
Binding of purified multiple antibiotic-resistance repressor protein (MarR) to mar operator sequences.
Proc. Natl. Acad. Sci. USA
92:5456-5460[Abstract/Free Full Text].
|
| 37.
|
McFall, S. M.,
T. J. Klem,
N. Fujita,
A. Ishihama, and A. M. Chakrabarty.
1997.
DNase I footprinting, DNA bending and in vitro transcription analyses of ClcR and CatR interactions with the clcABD promoter: evidence of a conserved transcriptional activation mechanism.
Mol. Microbiol.
24:965-976[CrossRef][Medline].
|
| 38.
|
Nakatsu, C.,
J. Ng,
R. Singh,
N. Straus, and C. Wyndham.
1991.
Chlorobenzoate catabolic transposon Tn5271 is a composite class I element with flanking class II insertion sequences.
Proc. Natl. Acad. Sci. USA
88:8312-8316[Abstract/Free Full Text].
|
| 39.
|
Nakatsu, C. H.,
R. R. Fulthorpe,
B. A. Holland,
M. C. Peel, and R. C. Wyndham.
1995.
The phylogenetic distribution of a transposable dioxygenase from the Niagara River watershed.
Mol. Ecol.
4:593-603[Medline].
|
| 40.
|
Nakatsu, C. H.,
M. Providenti, and R. C. Wyndham.
1997.
The cis-diol dehydrogenase cbaC gene of Tn5271 is required for growth on 3-chlorobenzoate but not 3,4-dichlorobenzoate.
Gene
196:209-218[CrossRef][Medline].
|
| 41.
|
Nakatsu, C. H., and R. C. Wyndham.
1993.
Cloning and expression of the transposable chlorobenzoate-3,4-dioxygenase genes of Alcaligenes sp. strain BR60.
Appl. Environ. Microbiol.
59:3625-3633[Abstract/Free Full Text].
|
| 42.
|
Ng, J., and R. C. Wyndham.
1993.
IS1071-mediated recombinational equilibrium in Alcaligenes sp. BR60 carrying the 3-chlorobenzoate catabolic transposon Tn5271.
Can. J. Microbiol.
39:92-100.
|
| 43.
|
Oscarsson, J.,
Y. Mizunoe,
B. E. Uhlin, and D. J. Haydon.
1996.
Induction of haemolytic activity in Escherichia coli by the slyA gene product.
Mol. Microbiol.
20:191-199[Medline].
|
| 44.
|
Parsek, M. R.,
M. Kivisaar, and A. M. Chakrabarty.
1995.
Differential DNA bending introduced by the Pseudomonas putida LysR-type regulator, CatR, at the plasmid-borne pheBA and chromosomal catBC promoters.
Mol. Microbiol.
15:819-828[Medline].
|
| 45.
|
Parsek, M. R.,
S. M. McFall,
D. L. Shinabarger, and A. M. Chakrabarty.
1994.
Interaction of two LysR-type regulatory proteins CatR and ClcR with heterologous promoters: functional and evolutionary implications.
Proc. Natl. Acad. Sci. USA
91:12393-12397[Abstract/Free Full Text].
|
| 46.
|
Peel, M. C., and R. C. Wyndham.
1997.
The impact of industrial contamination on microbial chlorobenzoate degradation in the Niagara watershed.
Microb. Ecol.
33:59-68[CrossRef][Medline].
|
| 47.
|
Peel, M. C., and R. C. Wyndham.
1999.
Selection of clc, cba, and fcb chlorobenzoate-catabolic genotypes from groundwater and surface waters adjacent to the Hyde Park, Niagara Falls, chemical landfill.
Appl. Environ. Microbiol.
65:1627-1635[Abstract/Free Full Text].
|
| 48.
|
Poole, K.,
K. Tetro,
Q. Zhao,
S. Neshat,
D. E. Heinrichs, and N. Bianco.
1996.
Expression of the multidrug resistance operon mexA-mexB-oprM in Pseudomonas aeruginosa: mexR encodes a regulator of operon expression.
Antimicrob. Agents Chemother.
40:2021-2028[Abstract].
|
| 49.
|
Praillet, T.,
W. Nasser,
J. Robert-Baudouy, and S. Reverchon.
1996.
Purification and functional characterization of PecS, a regulator of virulence-factor synthesis in Erwinia chrysanthemi.
Mol. Microbiol.
20:391-402[CrossRef][Medline].
|
| 50.
|
Providenti, M. A.,
J. Mampel,
S. MacSween,
A. M. Cook, and R. C. Wyndham.
2001.
Comamonas testosteroni BR6020 possesses a single genetic locus for extradiol cleavage of protocatechuate.
Microbiology
147:2157-2167[Abstract/Free Full Text].
|
| 51.
|
Reverchon, S.,
W. Nasser, and J. Robert-Baudouy.
1994.
pecS: a locus controlling pectinase, cellulase and blue pigment production in Erwinia chrysanthemi.
Mol. Microbiol.
11:1127-1139[CrossRef][Medline].
|
| 52.
|
Roper, D. I.,
T. Fawcett, and R. A. Cooper.
1993.
The Escherichia coli C homoprotocatechuate degradative operon: hpc gene order, direction of transcription and control of expression.
Mol. Gen. Genet.
237:241-250[Medline].
|
| 53.
|
Rothmel, R. K.,
A. M. Chakrabarty,
A. Berry, and A. Darzins.
1991.
Genetic systems in Pseudomonas.
Methods Enzymol.
204:485-514[Medline].
|
| 54.
|
Rouanet, C.,
K. Nomura,
S. Tsuyumu, and W. Nasser.
1999.
Regulation of pelD and pelE, encoding major alkaline pectate lyases in Erwinia chrysanthemi: involvement of the main transcriptional factors.
J. Bacteriol.
181:5948-5957[Abstract/Free Full Text].
|
| 55.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 56.
|
Seoane, A. S., and S. B. Levy.
1995.
Characterization of MarR, the repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli.
J. Bacteriol.
177:3414-3419[Abstract/Free Full Text].
|
| 57.
|
Srikumar, R.,
C. J. Paul, and K. Poole.
2000.
Influence of mutations in the mexR repressor gene on expression of the MexA-MexB-OprM multidrug efflux system of Pseudomonas aeruginosa.
J. Bacteriol.
182:1410-1414[Abstract/Free Full Text].
|
| 58.
|
Sulavik, M. C.,
L. F. Gambino, and P. F. Miller.
1995.
The MarR repressor of the multiple antibiotic resistance (mar) operon in Escherichia coli: prototypic member of a family of bacterial regulatory proteins involved in sensing phenolic compounds.
Mol. Med.
1:436-446[Medline].
|
| 59.
|
Tamaoka, J.,
D. M. Ha, and K. Komagata.
1987.
Reclassification of Pseudomonas acidovorans den Dooren de Jong 1926 and Pseudomonas testosteroni Marcus and Talalay 1956 as Comamonas acidovorans comb. nov. and Comamonas testosteroni comb. nov., with an emended description of the genus Comamonas.
Int. J. Syst. Bacteriol.
37:52-59.
|
| 60.
|
Tsoi, T. V.,
E. G. Plotnikova,
J. R. Cole,
W. F. Guerin,
M. Bagdasarian, and J. M. Tiedje.
1999.
Cloning, expression, and nucleotide sequence of the Pseudomonas aeruginosa 142 ohb genes coding for oxygenolytic ortho dehalogenation of halobenzoates.
Appl. Environ. Microbiol.
65:2151-2162[Abstract/Free Full Text].
|
| 61.
|
Tsoi, T. V.,
G. M. Zaitsev,
E. G. Plotnikova,
I. A. Kosheleva, and A. M. Boronin.
1991.
Cloning and expression of the Arthrobacter globiformis KZT1 fcbA gene encoding dehalogenase (4-chlorobenzoate-4-hydroxylase) in Escherichia coli.
FEMS Microbiol. Lett.
65:165-169[CrossRef][Medline].
|
| 62.
|
Wheelis, M. L.,
N. J. Palleroni, and R. Y. Stanier.
1967.
The metabolism of aromatic acids by Pseudomonas testosteroni and P. acidovorans.
Arch. Microbiol.
59:302-314.
|
| 63.
|
Wilmes-Riesenberg, M. R., and B. L. Wanner.
1992.
TnphoA and TnphoA' elements for making and switching fusions for study of transcription, translation, and cell surface localization.
J. Bacteriol.
174:4558-4575[Abstract/Free Full Text].
|
| 64.
|
Wyndham, R. C.
1986.
Evolved aniline catabolism in Acinetobacter calcoaceticus during continuous culture of river water.
Appl. Environ. Microbiol.
51:781-789[Abstract/Free Full Text].
|
| 65.
|
Wyndham, R. C.,
C. Nakatsu,
M. Peel,
A. Cashore,
J. Ng, and F. Szilagyi.
1994.
Distribution of the catabolic transposon Tn5271 in a groundwater bioremediation system.
Appl. Environ. Microbiol.
60:86-93[Abstract/Free Full Text].
|
| 66.
|
Wyndham, R. C.,
R. K. Singh, and N. A. Straus.
1988.
Catabolic instability, plasmid gene deletion and recombination in Alcaligenes sp. BR60.
Arch. Microbiol.
150:237-243[CrossRef][Medline].
|
| 67.
|
Wyndham, R. C., and N. A. Straus.
1988.
Chlorobenzoate catabolism and interactions between Alcaligenes and Pseudomonas species from Bloody Run Creek.
Arch. Microbiol.
150:230-236[CrossRef][Medline].
|
| 68.
|
Yanisch-Perron, C.,
J. Vieira, and J. Messing.
1985.
Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.
Gene
33:103-119[CrossRef][Medline].
|
Applied and Environmental Microbiology, August 2001, p. 3530-3541, Vol. 67, No. 8
0099-2240/01/$04.00+0 DOI: 10.1128/AEM.67.8.3530-3541.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Daigle, D. M., Cao, L., Fraud, S., Wilke, M. S., Pacey, A., Klinoski, R., Strynadka, N. C., Dean, C. R., Poole, K.
(2007). Protein Modulator of Multidrug Efflux Gene Expression in Pseudomonas aeruginosa. J. Bacteriol.
189: 5441-5451
[Abstract]
[Full Text]
-
Providenti, M. A., O'Brien, J. M., Ruff, J., Cook, A. M., Lambert, I. B.
(2006). Metabolism of Isovanillate, Vanillate, and Veratrate by Comamonas testosteroni Strain BR6020. J. Bacteriol.
188: 3862-3869
[Abstract]
[Full Text]
-
Wilkinson, S. P., Grove, A.
(2004). HucR, a Novel Uric Acid-responsive Member of the MarR Family of Transcriptional Regulators from Deinococcus radiodurans. J. Biol. Chem.
279: 51442-51450
[Abstract]
[Full Text]
-
Tropel, D., van der Meer, J. R.
(2004). Bacterial Transcriptional Regulators for Degradation Pathways of Aromatic Compounds. Microbiol. Mol. Biol. Rev.
68: 474-500
[Abstract]
[Full Text]
-
Galan, B., Kolb, A., Sanz, J. M., Garcia, J. L., Prieto, M. A.
(2003). Molecular determinants of the hpa regulatory system of Escherichia coli: the HpaR repressor. Nucleic Acids Res
31: 6598-6609
[Abstract]
[Full Text]
-
Parke, D., Ornston, L. N.
(2003). Hydroxycinnamate (hca) Catabolic Genes from Acinetobacter sp. Strain ADP1 Are Repressed by HcaR and Are Induced by Hydroxycinnamoyl-Coenzyme A Thioesters. Appl. Environ. Microbiol.
69: 5398-5409
[Abstract]
[Full Text]
-
Bartosik, D., Sochacka, M., Baj, J.
(2003). Identification and Characterization of Transposable Elements of Paracoccus pantotrophus. J. Bacteriol.
185: 3753-3763
[Abstract]
[Full Text]
-
Sota, M., Endo, M., Nitta, K., Kawasaki, H., Tsuda, M.
(2002). Characterization of a Class II Defective Transposon Carrying Two Haloacetate Dehalogenase Genes from Delftia acidovorans Plasmid pUO1. Appl. Environ. Microbiol.
68: 2307-2315
[Abstract]
[Full Text]